pirinixic acid has been researched along with Muscular Atrophy in 1 studies
pirinixic acid: structure
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ringseis, R | 1 |
| Keller, J | 1 |
| Lukas, I | 1 |
| Spielmann, J | 1 |
| Most, E | 1 |
| Couturier, A | 1 |
| König, B | 1 |
| Hirche, F | 1 |
| Stangl, GI | 1 |
| Wen, G | 1 |
| Eder, K | 1 |
1 other study available for pirinixic acid and Muscular Atrophy
| Article | Year |
|---|---|
Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents.
Topics: Animals; Anticholesteremic Agents; Clofibrate; Humans; Hyperlipidemias; Mice; Mice, Knockout; Muscle | 2013 |